Buenos Aires ophthalmologist and retinal specialist Dr Patricio Schlottmann discusses the challenges of delivering ongoing treatment for retinal conditions in South America.
Speaking with mivision at the recent Asia-Pacific Vitreo-retina Society (APVRS) congress on the Gold Coast, Dr Schlottmann shares his perspective on the retinal disease landscape in Argentina and across the region, including the impact of the burden of frequent intravitreal injections.
He also discusses Roche’s Port Delivery Platform and the potential for sustained drug delivery to reduce this burden.
